A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

248

Participants

Timeline

Start Date

August 10, 2016

Primary Completion Date

January 4, 2018

Study Completion Date

January 4, 2018

Conditions

Pneumonia

Interventions

BIOLOGICAL

PATH-wSP

Streptococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide

BIOLOGICAL

Placebo

Normal Saline

Trial Locations (1)

KEMRI-Wellcome Trust Research Programme; Centre for Geographic Medicine Research - Coast, Kilifi

All Listed Sponsors

lead

PATH

OTHER

NCT02543892 - A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya | Biotech Hunter | Biotech Hunter